U.S. RESEARCH ROUNDUP-Covia Holdings, Gamida Cell, Varonis Systems

Energy Recovery

01/07/2020 08:17

July 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Covia Holdings, Gamida Cell and Varonis Systems, on
Wednesday. 
    
    HIGHLIGHTS
     * Covia Holdings Corp  CVIA.N : RBC cuts to underperform from sector perform
     * Gamida Cell Ltd  GMDA.O : Evercore ISI initiates with outperform rating
     * Legend Biotech Corp  LEGN.O : JP Morgan initiates with overweight, $50 target price
     * Varonis Systems Inc  VRNS.O : JP Morgan starts with overweight rating; target price $130
        
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order. 
     * Akero Therapeutics Inc  AKRO.O : Canaccord Genuity raises price target to $51 from $36
     * Akero Therapeutics Inc  AKRO.O : Evercore ISI raises target price to $80 from $35
     * Churchill Downs Inc  CHDN.O : JP Morgan raises target price to $148 from $138
     * Citizens Financial Group Inc  CFG.N : RBC cuts target price to $29 from $35
     * Conagra Brands Inc  CAG.N : Credit Suisse raises target price to $38 from $36
     * Concho Resources Inc  CXO.N : JP Morgan raises target price to $65 from $60
     * Corning Inc  GLW.N : Citigroup raises price target to $32 from $24
     * Covia Holdings Corp  CVIA.N : RBC cuts to underperform from sector perform
     * Covia Holdings Corp  CVIA.N : RBC cuts target price to $0.05 from $1
     * Energy Recovery Inc  ERII.O : Evercore ISI cuts target price to $12 from $16
     * Fedex Corp  FDX.N : Cowen and Company raises target price to $167 from $156
     * Fifth Third Bancorp  FITB.O : RBC cuts target price to $24 from $28
     * First Industrial Realty Trust Inc  FR.N : RBC raises target price to $43 from $41
     * Gamida Cell Ltd  GMDA.O : Evercore ISI initiates with outperform rating
     * GW Pharmaceuticals Plc  GWPH.O : Evercore ISI raises target price to $275 from $250
     * Hudson Pacific Properties Inc  HPP.N : Jefferies raises target price to $25 from $24
     * Intercept Pharmaceuticals Inc  ICPT.O : Citigroup cuts price target to $67 from $110
     * Keycorp  KEY.N : RBC cuts target price to $13 from $16
     * Kimco Realty Corp  KIM.N : Piper Sandler raises target price to $14 from $12
     * Legend Biotech Corp  LEGN.O : Jefferies initiates with buy, $47 target price
     * Legend Biotech Corp  LEGN.O : JP Morgan initiates with overweight, $50 target price
     * Northern Trust Corp  NTRS.O : RBC cuts target price to $80 from $85
     * Parker-Hannifin Corp  PH.N : Jefferies raises target price to $210 from $190
     * Phathom Pharmaceuticals Inc  PHAT.O : Jefferies raises target price to $38 from $32
     * Regions Financial Corp  RF.N : RBC cuts target price to $13 from $16
     * Ultragenyx Pharmaceutical Inc  RARE.O : SunTrust Robinson raises PT to $88 from $82
     * Ultragenyx Pharmaceutical Inc  RARE.O : SVB Leerink raises target price to $89 from $85
     * Varonis Systems Inc  VRNS.O : JP Morgan starts with overweight rating; target price $130
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))